JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, Y.
Right arrow Articles by Sugiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, Y.
Right arrow Articles by Sugiyama, Y.

Vol. 288, Issue 2, 568-574, February 1999

Hepatobiliary Transport Governs Overall Elimination of Peptidic Endothelin Antagonists in Rats

Yukio Kato, Sharif Akhteruzzaman, Akihiro Hisaka and Yuichi Sugiyama

Graduate School of Pharmaceutical Sciences, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan (S.A., Y.K., Y.S.); and Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Okubo, Tsukuba, Japan (A.H.)

The overall disposition and hepatobiliary transport of BQ-123, an anionic cyclopentapeptide, and three analogs were examined in rats in vivo. Total body clearance (CLtotal) and biliary excretion clearance (CLbile, p) exhibited 4- to 8-fold differences between the compounds, with those for BQ-485 and compound A having the highest and lowest values, respectively. The CLbile, p values of BQ-485, BQ-123, and BQ-518 were almost equal to the CLtotal, suggesting that hepatobiliary transport is the major elimination pathway for these compounds. Hepatic uptake clearance (CLuptake, vivo) and biliary excretion clearance (CLbile, h/fT), which was defined for the hepatic unbound concentration, were separately determined to examine the hepatic uptake and excretion processes, respectively. Both the CLuptake, vivo and CLbile, h/fT of BQ-485 were higher than those of BQ-123, whereas the corresponding values for BQ-518 were similar to those for BQ-123. The CLuptake, vivo and CLbile, h/fT of compound A were, respectively, approximately two thirds and one half those of BQ-123, suggesting that the lower CLbile, p value is due to the low efficiency of both the uptake and excretion processes. The CLuptake, vivo of these four peptides in vivo was similar to the extrapolated values based on the carrier-mediated transport activity previously assessed in vitro in isolated rat hepatocytes. The primary active transport previously assessed in an in vitro study in canalicular membrane vesicles was also highest for BQ-485 and lowest for compound A, similar to CLbile, h/fT in vivo. Thus, the transporters on both the sinusoidal and canalicular membranes determine the efficiency of the peptide overall elimination from the circulation.


0022-3565/99/2882-0568$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
R. Nasu, Y. Kumagai, H. Kogetsu, M. Tsujimoto, H. Ohtani, and Y. Sawada
PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR PRALMORELIN HYDROCHLORIDE IN RATS
Drug Metab. Dispos., October 1, 2005; 33(10): 1488 - 1494.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Sasaki, H. Suzuki, J. Aoki, K. Ito, P. J. Meier, and Y. Sugiyama
Prediction of in Vivo Biliary Clearance from the in Vitro Transcellular Transport of Organic Anions across a Double-Transfected Madin-Darby Canine Kidney II Monolayer Expressing Both Rat Organic Anion Transporting Polypeptide 4 and Multidrug Resistance Associated Protein 2
Mol. Pharmacol., September 1, 2004; 66(3): 450 - 459.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. Houle, J. Raoul, J.-F. Levesque, K. S. Pang, D. A. Nicoll-Griffith, and J. M. Silva
Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes
Drug Metab. Dispos., April 1, 2003; 31(4): 447 - 451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Gotoh, Y. Kato, B. Stieger, P. J. Meier, and Y. Sugiyama
Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta -D-glucuronide in rats
Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1245 - E1254.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Akhteruzzaman, Y. Kato, H. Kouzuki, H. Suzuki, A. Hisaka, B. Stieger, P. J. Meier, and Y. Sugiyama
Carrier-Mediated Hepatic Uptake of Peptidic Endothelin Antagonists in Rats
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1107 - 1115.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Akhteruzzaman, Y. Kato, A. Hisaka, and Y. Sugiyama
Primary Active Transport of Peptidic Endothelin Antagonists by Rat Hepatic Canalicular Membrane
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 575 - 581.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.